Summary: Drug Testing Integrity Act of 2011 - Makes it unlawful to knowingly manufacture, market, sell, ship, or otherwise provide to another individual any product with the intent to assist such individual to use such product to defraud a drug test. Treats a violation of this Act as an unfair or deceptive act or practice under the Federal Trade Commission Act.

drug testing integrity act makes unlawful knowingly manufacture market sell ship provide individual product intent assist individual use product defraud drug test treats violation act unfair deceptive act practice federal_trade_commission_act


Summary: Federal Lands Counterdrug Strategy Act - Requires the Director of National Drug Control Policy to develop and submit to Congress a Federal Lands Counterdrug Strategy. Sets forth specific Strategy requirements.

strategy act requires director national_drug_control_policy develop submit sets forth specific strategy requirements


Summary: Pill Mill Crackdown Act of 2011 - Amends the Controlled Substances Act to: (1) double the term of imprisonment and triple the fine for the prohibited distribution of a schedule II or schedule III controlled substance by the operator of a pill mill, (2) increase the penalties for such operator distribution of a controlled substance to a person under age 21 from twice to thrice the maximum punishment or term of supervised release authorized, and (3) exclude such operator distribution from the applicability of provisions authorizing an alternative fine of not more than twice the gross profits or other proceeds derived by a defendant from a drug offense. Expresses the sense of Congress that such prohibited operator distribution is a violation for which certain property is subject to forfeiture. Requires the proceeds from disposition of such property to be used for controlled substance monitoring programs in the states and for block grants to states for community mental health services and for prevention and treatment of substance abuse. Changes the classification of specified quantities of dihydrocodeinone from a schedule III to a schedule II controlled substance.

amends controlled substances act double term imprisonment triple fine prohibited distribution schedule schedule iii controlled substance operator mill increase penalties operator distribution controlled substance person age twice maximum punishment term supervised release authorized exclude operator distribution applicability provisions authorizing alternative fine twice gross profits proceeds derived defendant drug offense expresses sense congress prohibited operator distribution violation certain property subject forfeiture requires proceeds disposition property controlled substance monitoring programs states block grants states community mental health services prevention treatment substance abuse changes classification specified quantities schedule iii schedule controlled substance


Summary: Synthetic Drug Control Act of 2011 - Amends the Controlled Substances Act to add as schedule I controlled substances: (1) any material, compound, mixture, or preparation which contains specified cannabimimetic agents (or the salts, isomers, or salts of isomers thereof); and (2) specified additional hallucinogenic substances (or the salts, isomers, or salts of isomers thereof). Extends the period for which the Attorney General may temporarily schedule a substance in schedule I to avoid an imminent hazard to public safety to two years with a one-year extension (currently, one year with a six-month extension).

amends controlled substances act add schedule controlled substances material compound mixture preparation contains specified cannabimimetic agents salts isomers salts isomers thereof specified additional substances salts isomers salts isomers thereof extends period attorney general temporarily schedule substance schedule avoid imminent hazard public safety years year extension currently year month extension


Summary: Fraudulent Prescription Prevention Act of 2011 - Amends the Controlled Substances Act to prohibit the Attorney General from registering a practitioner to dispense or conduct research with a schedule II or III controlled substance unless the practitioner agrees to comply with this Act's requirements. Requires a practitioner, at the time of prescribing such substances to submit to the Attorney General by means of a web portal: (1) the patient's name, date of birth, and address; (2) the date and time of the prescription; (3) the name and amount of the substance prescribed; (4) the practitioner's Drug Enforcement Administration (DEA) registration number and contact information; and (5) the prescription pad number. Makes exceptions if the practitioner is prescribing a controlled substance in a medical emergency situation or does not have access to the web portal (in which case the practitioner may make the required submissions within seven days). Requires a practitioner to submit the same information before dispensing such a controlled substance, as well as whether the dispensing constitutes a refill of a prescription. Requires a practitioner who declines to dispense such a controlled substance to submit information that would have been required to be reported if the substance had been dispensed and any reason to suspect that the individual attempting to purchase the substance was acting pursuant to fraud. Directs the Attorney General to establish and maintain a web portal and database that allows a practitioner to submit such information and that communicates an alert to the practitioner if circumstances exist that indicate the patient or purchaser is attempting to unlawfully divert or misuse a controlled substance. Limits disclosure of database information.

fraudulent prescription prevention act amends controlled substances act prohibit attorney general registering practitioner dispense conduct research schedule iii controlled substance practitioner agrees comply act requirements requires practitioner time prescribing substances submit attorney general means web portal patient date birth address date time prescription substance prescribed practitioner drug_enforcement_administration dea registration number contact information prescription pad number makes exceptions practitioner prescribing controlled substance medical emergency situation access web portal case practitioner required submissions seven days requires practitioner submit information dispensing controlled substance dispensing constitutes prescription requires practitioner declines dispense controlled substance submit information required reported substance dispensed reason suspect individual attempting purchase substance acting pursuant fraud directs attorney general establish maintain web portal database allows practitioner submit information communicates alert practitioner circumstances exist indicate patient purchaser attempting unlawfully divert misuse controlled substance limits disclosure database information


Summary: Directs the Secretary of State to designate as a foreign terrorist organization each of the following: (1) the Arellano Feliz Organization, (2) the Los Zetas Cartel, (3) the Beltran Leyva Organization, (4) La Familia Michoacana, (5) the Sinaloa Cartel, and (6) the Gulf Cartel/New Federation.

directs secretary state designate foreign terrorist organization following cartel gulf cartel new federation


Summary: Opiate Addiction Treatment Act of 2011 - Amends the Controlled Substances Act to authorize a nurse practitioner with a graduate nursing degree to dispense certain narcotic drugs in schedule III, IV, and V for maintenance treatment or detoxification treatment without obtaining annually a separate registration for that purpose.

amends controlled substances act authorize nurse practitioner graduate nursing degree dispense certain narcotic drugs schedule iii maintenance treatment detoxification treatment obtaining annually separate registration purpose


Summary: Fairness in Cocaine Sentencing Act of 2011 - Amends the Controlled Substances Act and the Controlled Substances Import and Export Act to eliminate increased and mandatory minimum penalties for drug offenses involving mixtures or substances which contain cocaine base (i.e., crack cocaine).

fairness amends controlled substances act controlled_substances_import_and_export_act eliminate increased mandatory minimum penalties drug offenses involving mixtures substances contain cocaine base crack cocaine


Summary: Border Tunnel Prevention Act of 2011 - Amends the federal criminal code to: (1) subject anyone who attempts or conspires to construct or finance construction of an unauthorized tunnel or subterranean passage that crosses the international border between the United States and another country, to use such a tunnel for smuggling, or to disregard such construction or use, to the penalties prescribed for someone who commits such an offense; (2) make such a border tunnel offense a predicate offense for a money laundering violation and for authorization for interception of wire, oral, or electronic communications; and (3) provide for the criminal forfeiture of proceeds of such an offense and the seizure and forfeiture of merchandise introduced into the United States through such a tunnel. Encourages the Secretary of Homeland Security (DHS) to annually provide each known nongovernmental owner and tenant of land located in a national security zone with a written notification that describes federal laws related to the construction of illegal border tunnels and the procedures for reporting violations of such laws to U.S. Immigration and Customs Enforcement (ICE). Defines: (1) "national security zone" as any Southwest Border land designated by the Secretary as being at a high risk for border tunnel activity; and (2) "Southwest Border land" as all parcels of real property in the United States that are located within one mile of the U.S.-Mexico international border and that are not owned by a federal, state, tribal, or local government entity. Requires the Secretary to submit an annual report describing: (1) cross border tunnels discovered in Southwest Border land; and (2) DHS needs to effectively prevent, investigate, and prosecute border tunnel construction on such land.

border tunnel prevention act amends federal criminal code subject attempts conspires construct finance construction unauthorized tunnel subterranean passage crosses international border united_states country use tunnel smuggling disregard construction use penalties prescribed commits offense border tunnel offense predicate offense money laundering violation authorization interception wire oral electronic communications provide criminal forfeiture proceeds offense seizure forfeiture merchandise introduced united_states tunnel encourages secretary homeland_security dhs annually provide known nongovernmental owner tenant land located national security zone written notification describes federal laws related construction illegal border tunnels procedures reporting violations laws defines national security zone southwest_border land designated secretary high risk border tunnel activity southwest border land parcels real property united_states located mile international border owned federal state tribal local government entity requires secretary submit annual report describing cross border tunnels discovered southwest_border land dhs needs effectively prevent investigate prosecute border tunnel construction land


Summary: Major Drug Trafficking Prosecution Act of 2011- Requires the Attorney General's prior written approval for a federal prosecution of an offense under the Controlled Substances Act (CSA) or the Controlled Substances Import and Export Act (CSIEA), or for any conspiracy to commit such an offense, where the offense involves the illegal distribution or possession of a controlled substance in an amount less than that specified as a minimum for an offense under CSA or, in the case of any substance containing cocaine or cocaine base, in an amount less than 500 grams. Modifies CSA and CSIEA to delete specified mandatory minimum terms of imprisonment.

requires attorney general prior written approval federal prosecution offense controlled substances act csa controlled_substances_import_and_export_act csiea conspiracy commit offense offense involves illegal distribution possession controlled substance specified minimum offense csa case substance containing cocaine cocaine base grams modifies csa csiea delete specified mandatory minimum terms imprisonment


Summary: Ending Federal Marijuana Prohibition Act of 2011 - Amends the Controlled Substances Act (CSA) to: (1) provide that such Act shall not apply to marihuana, except that it shall be unlawful to ship or transport from one state, territory, or district (jurisdiction) of the United States to another, or from a foreign country into such a U.S. jurisdiction, marihuana that is intended to be received, possessed, sold, or in any manner used in violation of any law of such jurisdiction; and (2) remove marihuana and tetrahydrocannabinols from the list of Schedule I controlled substances. Amends the Controlled Substances Import and Export Act to exclude marijuana from its prohibitions on the import, export, manufacture, possession with intent to distribute, or distribution of a controlled substance.

amends controlled substances act csa provide act shall apply marihuana shall unlawful ship transport state territory district jurisdiction united_states foreign country jurisdiction marihuana intended received possessed sold manner violation law jurisdiction remove marihuana list schedule controlled substances amends controlled_substances_import_and_export_act exclude marijuana prohibitions import export manufacture possession intent distribute distribution controlled substance


Summary: Counterfeit Drug Penalty Enhancement Act of 2011 - Amends the federal criminal code to establish criminal penalties of a fine, imprisonment for life or any term of years, or both, for trafficking in counterfeit drugs. States that nothing in this Act shall be construed to apply to a drug solely because the drug is manufactured in or imported from a foreign country.

amends federal criminal code establish criminal penalties fine imprisonment life term years trafficking counterfeit drugs states act shall construed apply drug solely drug manufactured imported foreign country


Summary: Counterfeit Drug Penalty Enhancement Act of 2012 - Amends the federal criminal code to prohibit and to establish criminal penalties for trafficking, or attempting to traffic, in counterfeit drugs. Directs: (1) the Attorney General to give increased priority to efforts to investigate and prosecute offenses that involve trafficking in counterfeit drugs; and (2) the United States Sentencing Commission to review and, if appropriate, amend its guidelines and policy statements applicable to persons convicted of such offense to reflect congressional intent that penalties be increased to reflect the serious nature of such offense and the need for an effective deterrent and to account for the resulting harm to the public.

amends federal criminal code prohibit establish criminal penalties trafficking attempting traffic counterfeit drugs directs attorney general increased priority efforts investigate prosecute offenses involve trafficking counterfeit drugs united_states_sentencing_commission review appropriate amend guidelines policy statements applicable persons convicted offense reflect congressional intent penalties increased reflect nature offense need effective deterrent account resulting harm public


Summary: Targeting Transnational Drug Trafficking Act of 2011 [sic] - Amends the Controlled Substances Import and Export Act to prohibit the manufacture or distribution of a controlled substance in schedule I or II, flunitrazepam, or a listed chemical by individuals having reasonable cause to believe that such substance or chemical will be unlawfully imported into the United States or into waters within 12 miles of the U.S. coast. Prohibits the manufacture or distribution of a listed chemical: (1) intending or knowing that it will be used to manufacture a controlled substance; and (2) intending, knowing, or having reasonable cause to believe that the substance will be unlawfully imported into the United States. Makes it sufficient to prove a conspiracy to commit an offense that requires the person to intend, know, or have reasonable cause to believe that a controlled substance will be unlawfully imported into the United States if only one member of the conspiracy had such intention, knowledge, or reasonable cause to believe.

targeting transnational drug trafficking act sic amends controlled_substances_import_and_export_act prohibit manufacture distribution controlled substance schedule flunitrazepam listed chemical individuals having reasonable cause believe substance chemical unlawfully imported united_states waters miles coast prohibits manufacture distribution listed chemical intending knowing manufacture controlled substance intending knowing having reasonable cause believe substance unlawfully imported united_states makes sufficient prove conspiracy commit offense requires person intend know reasonable cause believe controlled substance unlawfully imported united_states member conspiracy intention knowledge reasonable cause believe


Summary: Border Tunnel Prevention Act of 2012 - Amends the federal criminal code to: (1) subject anyone who attempts or conspires to construct or finance construction of an unauthorized tunnel or subterranean passage that crosses the international border between the United States and another country, or to use such a tunnel for smuggling, to the penalties prescribed for someone who commits such an offense; (2) make such a border tunnel offense a predicate offense for a money laundering violation and for authorization for interception of wire, oral, or electronic communications; and (3) provide for the criminal forfeiture of proceeds of such an offense and the seizure and forfeiture of merchandise introduced into the United States through such a tunnel. Expresses the sense of Congress that the Department of Homeland Security (DHS) should continue outreach efforts to educate landowners and tenants in areas along the border between Mexico and the United States about cross-border tunnels and seek their assistance in combating tunnel construction. Requires the Secretary of Homeland Security to submit an annual report describing: (1) cross-border tunnels along the U.S.-Mexico border discovered during the preceding fiscal year; and (2) the needs of DHS to effectively prevent, investigate, and prosecute construction of such tunnels.

border tunnel prevention act amends federal criminal code subject attempts conspires construct finance construction unauthorized tunnel subterranean passage crosses international border united_states country use tunnel smuggling penalties prescribed commits offense border tunnel offense predicate offense money laundering violation authorization interception wire oral electronic communications provide criminal forfeiture proceeds offense seizure forfeiture merchandise introduced united_states tunnel expresses sense congress department_of_homeland_security dhs continue outreach efforts educate landowners tenants areas border mexico united_states cross border tunnels seek assistance combating tunnel construction requires secretary homeland_security submit annual report describing cross border tunnels border discovered preceding fiscal year needs dhs effectively prevent investigate prosecute construction tunnels


Summary: Access to Substance Abuse Treatment Act of 2012 - Amends the Public Health Service Act to authorize the Secretary of Health and Human Services (HHS) to make grants to: (1) increase the availability of treatment for abuse of heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and phencyclidine (PCP); (2) provide vouchers to individuals in underserved populations for authorized services related to such treatment; and (3) establish programs to provide for and coordinate the provision of wrap-around services, such as medical services, job training services, and housing assistance, to affected by such substances. Revises the grant program to provide residential substance abuse treatment to pregnant and postpartum women to: (1) make caregiver parents eligible for such program, (2) make Indian tribes and tribal organizations eligible for grants, and (3) set forth the priority for allocation of grants. Requires the Director of the National Institute on Drug Abuse to conduct research on the effectiveness of the use of agonist and antagonist drugs to reduce the problems associated with stimulant abuse, including cocaine and methamphetamine abuse. Requires the Secretary to seek to enter into a contract with the Institute of Medicine to complete a literature review on the effectiveness of agonist and antagonist drugs for the treatment of stimulant abuse, including cocaine and methamphetamine abuse. Requires the Comptroller General to study: (1) the impact of the programs authorized by this Act on the effectiveness and availability of treatment for abuse of heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and phencyclidine; (2) how the level of federal funding available for such treatment compares to the amount necessary to provide adequate treatment; and (3) the impact of effective treatment on cost savings due to the reduced need for criminal justice and other services. Requires additional amounts authorized by this Act, prior to being appropriated, to be fully offset by a reduction to one or more other appropriations.

access substance abuse treatment act amends public_health_service_act authorize secretary health_and_human_services hhs grants increase availability treatment abuse heroin cocaine methamphetamine provide vouchers individuals underserved populations authorized services related treatment establish programs provide coordinate provision services medical services job training services housing assistance affected substances revises grant program provide residential substance abuse treatment pregnant postpartum women caregiver parents eligible program indian tribes tribal organizations eligible grants set forth priority allocation grants requires director conduct research effectiveness use drugs reduce problems associated abuse including cocaine methamphetamine abuse requires secretary seek enter contract institute_of_medicine complete literature review effectiveness drugs treatment abuse including cocaine methamphetamine abuse requires comptroller general study impact programs authorized act effectiveness availability treatment abuse heroin cocaine methamphetamine level federal funding available treatment compares necessary provide adequate treatment impact effective treatment cost savings reduced need criminal justice services requires additional amounts authorized act prior appropriated fully offset reduction appropriations


Summary: United States-Mexico Cross-Border Security Act of 2012 - Directs the President, through the National Security Council Interagency Group, to develop a Whole-of-Government Plan in coordination with the government of Mexico to combat Mexican-based transnational criminal organizations. Establishes the National Security Council Interagency Group composed of representatives at the Deputy Secretary level from the Department of State, the Department of Homeland Security (DHS), the Department of Justice (DOJ), the Department of the Treasury, the Department of Defense (DOD), and the National Security Council (NSC).

united_states- mexico cross border security act directs president develop government plan coordination government mexico combat mexican based transnational criminal organizations establishes composed representatives deputy secretary level department_of_state department_of_homeland_security dhs department_of_justice doj department_of_the_treasury department_of_defense dod national_security_council


Summary: Synthetic Cathinones Control Act of 2012 - Amends the Controlled Substances Act to add as schedule I controlled substances specified additional hallucinogenic substances (or the salts, isomers, or salts of isomers thereof).

synthetic control act amends controlled substances act add schedule controlled substances specified additional substances salts isomers salts isomers thereof


Summary: Athlete Due Process Protection Act of 2012 - Amends the Office of National Drug Control Policy Reauthorization Act of 2006 to direct the U.S. Anti-Doping Agency to provide a document to each athlete that it investigates that includes the specific doping allegations against such athlete. Requires the Agency's annual report to include: (1) information on each athlete the Agency investigated, including a copy of such document, the athlete's status as an amateur athlete, and the athlete's nationality; (2) the location and cost of each investigation and adjudication the Agency conducted; and (3) any investigations or adjudications conducted by the Agency that another U.S. or foreign agency or organization concurrently investigated or adjudicated. Requires the Agency, before a new or revised procedural or evidentiary rule that relates to the Agency's investigation or adjudication process can take effect, to submit to specified congressional committees a report containing a copy of the rule, a concise general statement relating to it, and a list of actions that the Agency plans to take to implement it. Makes such rule effective 180 days after the Agency submits such report if Congress has not voted to override its implementation. Prohibits any athlete who participates in an event sponsored or licensed by the sport's national governing body, or otherwise subject to the jurisdiction of the U.S. Anti-Doping Agency, the World Anti-Doping Agency, or the International Association of Athletics Federation, from being fined, suspended, expelled, or otherwise penalized unless such athlete has been: (1) served with written specific charges providing dates and times of alleged conduct in question, (2) given a reasonable time to prepare his or her defense, and (3) afforded a full and fair hearing.

athlete process protection act amends office_of_national_drug_control_policy_reauthorization_act direct provide document athlete includes specific doping allegations athlete requires agency annual report include information athlete agency investigated including copy document athlete status amateur athlete athlete nationality location cost investigation adjudication agency conducted investigations adjudications conducted agency foreign agency organization concurrently investigated adjudicated requires agency new revised procedural evidentiary rule relates agency investigation adjudication process effect submit specified congressional committees report containing copy rule concise general statement relating list actions agency plans implement makes rule effective days agency submits report congress voted override implementation prohibits athlete participates event sponsored licensed sport national governing body subject jurisdiction fined suspended penalized athlete served written specific charges providing dates times alleged conduct question given reasonable time prepare defense afforded fair hearing


Summary: Respect States' and Citizens' Rights Act of 2012 - Amends the Controlled Substances Act to provide that, in the case of any state law that pertains to marihuana, no provision of such Act shall be construed as indicating congressional intent to: (1) occupy the field in which that provision operates, including criminal penalties, to the exclusion of state law on the same subject matter; or (2) preempt any such state law.

amends controlled substances act provide case state law pertains marihuana provision act shall construed indicating congressional intent occupy field provision operates including criminal penalties exclusion state law subject matter preempt state law


Summary: Combating Dangerous Synthetic Stimulants Act of 2011 - Amends the Controlled Substances Act to include as a Schedule I controlled substance any material, compound, mixture, or preparation which contains 4-methylmethcathinone (Mephedrone) or 3,4-methylenedioxypyrovalerone (MDPV) or their salts, isomers, or salts of isomers.

act amends controlled substances act include schedule controlled substance material compound mixture preparation contains salts isomers salts isomers


Summary: Saving Kids from Dangerous Drugs Act of 2011 - Amends the Controlled Substances Act to make it unlawful for any adult (at least 18 years of age) to knowingly or intentionally manufacture or create, with intent to manufacture, create, distribute, or dispense, a Schedule I or II controlled substance that is: (1) combined with a beverage or candy product; (2) marketed or packaged to appear similar to a beverage or candy product; or (3) modified by flavoring or coloring with the intent to distribute, dispense, or sell it to a person under 18 years of age. Imposes enhanced criminal penalties for violations (not to exceed 10 years for a first offense or 20 years for a subsequent offense, involving the same controlled substance and schedule). Exempts any controlled substance that has been approved by the Secretary of Health and Human Services (HHS) under the drug approval process or that has been altered at the direction of a medical practitioner for a legitimate medical purpose.Directs the United States Sentencing Commission to review its guidelines and policy statements to reflect the enhanced penalties provided by this Act.

saving kids dangerous drugs act amends controlled substances act unlawful adult years age knowingly intentionally manufacture create intent manufacture create distribute dispense schedule controlled substance combined beverage candy product marketed packaged appear similar beverage candy product modified flavoring coloring intent distribute dispense sell person years age imposes enhanced criminal penalties violations exceed years offense years subsequent offense involving controlled substance schedule exempts controlled substance approved secretary health_and_human_services hhs drug approval process altered direction medical practitioner legitimate medical purpose directs united_states_sentencing_commission review guidelines policy statements reflect enhanced penalties provided act


Summary: Dangerous Synthetic Drug Control Act of 2011 or David Mitchell Rozga Act - Amends the Controlled Substances Act to add as a schedule I controlled substance any material, compound, mixture, or preparation which contains specified cannabimimetic agents (or the salts, isomers, or salts of isomers thereof). Extends the period during which the Attorney General may temporarily schedule a substance in schedule I to avoid an imminent hazard to public safety to two years with a one-year extension (currently, one year with a six-month extension).

dangerous synthetic drug control act controlled substances act add schedule controlled substance material compound mixture preparation contains specified cannabimimetic agents salts isomers salts isomers thereof extends period attorney general temporarily schedule substance schedule avoid imminent hazard public safety years year extension currently year month extension


Summary: Combating Designer Drugs Act of 2011 - Amends the Controlled Substances Act to include as a Schedule I controlled substance any material, compound, mixture, or preparation which contains: 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E); 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D); 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C); 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I); 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2); 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4); 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H); 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N); or 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).

combating designer amends controlled substances act include schedule controlled substance material compound mixture preparation contains


Summary: Border Tunnel Prevention Act of 2011 - Amends the federal criminal code to: (1) subject anyone who attempts or conspires to construct or finance construction of an unauthorized tunnel or subterranean passage that crosses the international border between the United States and another country, to use such a tunnel for smuggling, or to disregard such construction or use, to the penalties prescribed for someone who commits such an offense; (2) make such a border tunnel offense a predicate offense for a money laundering violation and for authorization for interception of wire, oral, or electronic communications; and (3) provide for the criminal forfeiture of proceeds of such an offense and the seizure and forfeiture of merchandise introduced into the United States through such a tunnel. Encourages the Secretary of Homeland Security (DHS) to annually provide each known nongovernmental owner and tenant of land located in a national security zone with a written notification that describes federal laws related to the construction of illegal border tunnels and the procedures for reporting violations of such laws to United States Immigration and Customs Enforcement (ICE). Defines: (1) "national security zone" as any Southwest Border land designated by the Secretary as being at a high risk for border tunnel activity; and (2) "Southwest Border land" as all parcels of real property in the United States that are located within one mile of the U.S.-Mexico international border and that are not owned by a federal, state, tribal, or local government entity. Requires the Secretary to submit an annual report describing: (1) cross border tunnels discovered in Southwest Border land; and (2) DHS needs to effectively prevent, investigate, and prosecute border tunnel construction on such land.


Summary: Targeting Transnational Drug Trafficking Act of 2011 - Amends the Controlled Substances Import and Export Act to prohibit the manufacture or distribution of a controlled substance in schedule I or II or flunitrazepam or a listed chemical by individuals having reasonable cause to believe that such substance or chemical will be unlawfully imported into the United States or into waters within 12 miles of the U.S. coast. Prohibits the manufacture or distribution of a listed chemical: (1) intending or knowing that it will be used to manufacture a controlled substance; and (2) intending, knowing, or having reasonable cause to believe that the substance will be unlawfully imported into the United States.

targeting transnational drug trafficking act amends controlled_substances_import_and_export_act prohibit manufacture distribution controlled substance schedule flunitrazepam listed chemical individuals having reasonable cause believe substance chemical unlawfully imported united_states waters miles coast prohibits manufacture distribution listed chemical intending knowing manufacture controlled substance intending knowing having reasonable cause believe substance unlawfully imported united_states


Summary: Drug Trafficking Safe Harbor Elimination Act of 2011 - Amends the Controlled Substances Act to provide that anyone within the United States who enters into a conspiracy to possess or traffic in controlled substances outside the United States, or who aids or abets others in such conduct, shall be subject to the same penalties that would apply to such conduct if it were to occur within the United States.

drug trafficking safe harbor elimination act amends controlled substances act provide united_states enters conspiracy possess traffic controlled substances outside united_states aids abets conduct shall subject penalties apply conduct occur united_states


Summary: Pill Mill Crackdown Act of 2011 - Amends the Controlled Substances Act to: (1) double the term of imprisonment and triple the fine for the prohibited distribution of a schedule II or schedule III controlled substance by the operator of a pill mill, (2) increase the penalties for such operator distribution of a controlled substance to a person under age 21 from twice to thrice the maximum punishment or term of supervised release authorized, and (3) exclude such operator distribution from the applicability of provisions authorizing an alternative fine of not more than twice the gross profits or other proceeds derived by a defendant from a drug offense. Defines: (1) "pill mill" to include a doctor's office, clinic, or health care facility that routinely prescribes or dispenses controlled substances outside the scope of the prevailing standards of medical practice in the community in relation to the prescribing or dispensing of controlled prescription drugs or that routinely violates such Act in relation to the prescribing or dispensing of controlled prescription drugs; and (2) "operator of a pill mill" to include any practicing physician affiliated with a pill mill or any owner, director, officer, or partner of a pill mill. Expresses the sense of Congress that such prohibited operator distribution is a violation for which certain property is subject to forfeiture. Requires the proceeds from disposition of such property to be used for controlled substance monitoring programs in the states and for block grants to states for community mental health services and for prevention and treatment of substance abuse. Changes the classification of specified quantities of dihydrocodeinone from a schedule III to a schedule II controlled substance.

amends controlled substances act double term imprisonment triple fine prohibited distribution schedule schedule iii controlled substance operator mill increase penalties operator distribution controlled substance person age twice maximum punishment term supervised release authorized exclude operator distribution applicability provisions authorizing alternative fine twice gross profits proceeds derived defendant drug offense defines mill include doctor office clinic health care facility routinely prescribes dispenses controlled substances outside scope prevailing standards medical practice community relation prescribing dispensing controlled prescription drugs routinely violates act relation prescribing dispensing controlled prescription drugs operator mill include practicing physician affiliated mill owner director officer partner mill expresses sense congress prohibited operator distribution violation certain property subject forfeiture requires proceeds disposition property controlled substance monitoring programs states block grants states community mental health services prevention treatment substance abuse changes classification specified quantities schedule iii schedule controlled substance


Summary: Counterfeit Drug Penalty Enhancement Act of 2011 - Amends the federal criminal code to establish criminal penalties of a fine, imprisonment for not more than 20 years, or both for trafficking, or attempting to traffic, in counterfeit drugs. Doubles the potential fine for repeat offenders. Directs the United States Sentencing Commission to review and, if appropriate, amend its guidelines and policy statements applicable to persons convicted of that offense to reflect congressional intent that such penalties be increased.

amends federal criminal code establish criminal penalties fine imprisonment years trafficking attempting traffic counterfeit drugs doubles potential fine repeat offenders directs united_states_sentencing_commission review appropriate amend guidelines policy statements applicable persons convicted offense reflect congressional intent penalties increased


Summary: Amends the Controlled Substances Act to remove dihydrocodeinone from classification as a schedule III controlled substance.

amends controlled substances act remove classification schedule iii controlled substance


Summary: Synthetic Drug Control Act of 2012 - Amends the Controlled Substances Act to add as schedule I controlled substances: (1) any material, compound, mixture, or preparation which contains specified cannabimimetic agents (or the salts, isomers, or salts of isomers thereof); and (2) specified additional hallucinogenic substances (or the salts, isomers, or salts of isomers thereof). Extends the period for which the Attorney General may temporarily schedule a substance in schedule I to avoid an imminent hazard to public safety to two years with a one-year extension (currently, one year with a six-month extension).

amends controlled substances act add schedule controlled substances material compound mixture preparation contains specified cannabimimetic agents salts isomers salts isomers thereof specified additional substances salts isomers salts isomers thereof extends period attorney general temporarily schedule substance schedule avoid imminent hazard public safety years year extension currently year month extension


Summary: Synthetic Drug Abuse Prevention Act of 2012- Amends the Controlled Substances Act to add as schedule I controlled substances: (1) any material, compound, mixture, or preparation which contains specified cannabimimetic agents (or the salts, isomers, or salts of isomers thereof); and (2) specified additional hallucinogenic substances (or the salts, isomers, or salts of isomers thereof). Extends the period for which the Attorney General may temporarily schedule a substance in schedule I to avoid an imminent hazard to public safety to two years with a one-year extension (currently, one year with a six-month extension).


Summary: Amends the Food and Nutrition Act of 2008 to prohibit any funds made available to carry out such Act from being provided to households in any state that allows income deductions for schedule I controlled substances, including medical marijuana.

amends food_and_nutrition_act prohibit funds available carry act provided households state allows income deductions schedule controlled substances including medical marijuana


Summary: Designer Anabolic Steroid Control Act of 2012 - Amends the Controlled Substances Act to:  (1) expand the list of substances defined as "anabolic steroids"; (2) authorize the Attorney General to issue a temporary order adding a drug or other substance to the list of anabolic steroids; (3) impose enhanced criminal and civil penalties for possessing or trafficking in any anabolic steroid, or product containing an anabolic steroid, unless it bears a label clearly identifying the anabolic steroid by the nomenclature used by the International Union of Pure and Applied Chemistry; and (4) authorize the Attorney General to collect data and analyze products to determine whether they contain anabolic steroids and are properly labeled. Specifies that a substance shall not be considered to be a drug or hormonal substance that is considered to be an anaboloic steroid if it is: (1) an herb or other botanical; (2) a concentrate, metabolite, or extract of, or a constituent isolated directly from, an herb or other botanical; (3) a combination of two or more such substances (i.e., botanical or concentrate, metabolite, or extract); or (4) a dietary ingredient for purposes of the Federal Food, Drug, and Cosmetic Act. Requires any person claiming the benefit of an exemption or exception from being considered a drug or hormonal substance shall bear the burden providing the appropriate evidence. Directs: (1) the United States Sentencing Commission to review and amend federal sentencing guidelines with respect to offenses involving anabolic steroids, and (2) the Administrator of the Drug Enforcement Administration (DEA) to report every two years on what anabolic steroids have been scheduled on a temporary basis under this Act.

designer anabolic steroid control act amends controlled substances act expand list substances defined anabolic steroids authorize attorney general issue temporary order adding drug substance list anabolic steroids impose enhanced criminal civil penalties possessing trafficking anabolic steroid product containing anabolic steroid bears label clearly identifying anabolic steroid international_union_of_pure_and_applied_chemistry authorize attorney general collect data analyze products determine contain anabolic steroids properly labeled specifies substance shall considered drug substance considered steroid botanical concentrate extract constituent isolated directly botanical combination substances botanical concentrate extract dietary ingredient purposes cosmetic act requires person claiming benefit exemption exception considered drug substance shall bear burden providing appropriate evidence directs united_states_sentencing_commission review amend federal sentencing guidelines respect offenses involving anabolic steroids administrator drug_enforcement_administration dea report years anabolic steroids scheduled temporary basis act


Summary: Industrial Hemp Farming Act of 2012 - Amends the Controlled Substances Act to exclude industrial hemp from the definition of "marihuana." Defines "industrial hemp" to mean the plant Cannabis sativa L. and any part of such plant, whether growing or not, with a delta-nine tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis. Deems Cannabis sativa L. to meet that concentration limit if a person grows or processes it for purposes of making industrial hemp in accordance with state law.

industrial hemp farming act amends controlled substances act exclude industrial hemp definition marihuana defines industrial hemp mean plant cannabis sativa plant growing delta tetrahydrocannabinol concentration percent dry weight basis sativa meet concentration limit person grows processes purposes making industrial hemp accordance state law


Summary:
No More Tulias: Drug Law Enforcement Evidentiary Standards Improvement Act of 2013 - Prohibits a state from receiving for a fiscal year any drug control and system improvement (Byrne) grant funds under the Omnibus Crime Control and Safe Streets Act of 1968, or any amount from any other law enforcement assistance program of the Department of Justice (DOJ), unless the state does not fund any antidrug task forces for that fiscal year or the state has in effect laws that ensure that: (1) a person is not convicted of a drug offense unless the facts that a drug offense was committed and that the person committed that offense are supported by evidence other than the eyewitness testimony of a law enforcement officer (officer) or individuals acting on an officer's behalf, and (2) an officer does not participate in a antidrug task force unless that officer's honesty and integrity is evaluated and found to be at an appropriately high level.

Requires states receiving federal funds under this Act to collect data on the racial distribution of drug charges, the nature of the criminal law specified in the charges, and the jurisdictions in which such charges are made.

drug law enforcement evidentiary standards improvement act prohibits state receiving fiscal year drug control system improvement byrne grant funds omnibus_crime_control_and_safe_streets_act law enforcement assistance program department_of_justice doj state fund antidrug task forces fiscal year state effect laws ensure person convicted drug offense facts drug offense committed person committed offense supported evidence eyewitness testimony law enforcement officer officer individuals acting officer behalf officer participate antidrug task force officer honesty integrity evaluated found appropriately high level requires states receiving federal funds act collect data racial distribution drug charges nature criminal law specified charges jurisdictions charges


Summary:
Synthetic Cathinones Control Act of 2013 - Directs the Attorney General to issue a final order within 60 days of this Act's enactment that schedules specified synthetic drugs on schedule I of the Controlled Substances Act.

 Amends the Controlled Substances Act to provide that Schedules I, II, III, IV, and V shall consist of the drugs and other substances that are set forth in the respective schedules in part 1308 of title 21 of the Code of Federal Regulations.

synthetic control act directs attorney general issue final order days act enactment schedules specified synthetic drugs schedule controlled substances act amends controlled substances act provide schedules iii shall consist drugs substances set forth respective schedules title code federal regulations


Summary:
Marijuana Tax Equity Act of 2013 - Amends the Internal Revenue Code to impose an excise tax on: (1) the sale of marijuana by producers or importers of such drug equal to 50% of the sales price, and (2) each person who is engaged in a marijuana enterprise. Defines "marijuana enterprise" to mean a producer, importer, manufacturer, distributor, retailer or any person who transports, stores, displays, or otherwise participates in any business activity that handles marijuana or marijuana products.

Requires any person who engages in a marijuana enterprise to obtain a permit to engage in such business. Imposes civil and criminal penalties for violations of the requirements of this Act.

amends internal revenue code impose excise tax sale marijuana producers importers drug equal sales price person engaged marijuana enterprise defines marijuana enterprise mean producer importer manufacturer distributor retailer person transports stores displays participates business activity handles marijuana marijuana products requires person engages marijuana enterprise obtain permit engage business imposes civil criminal penalties violations requirements act


Summary: Industrial Hemp Farming Act of 2013 - Amends the Controlled Substances Act to exclude industrial hemp from the definition of "marihuana." Defines "industrial hemp" to mean the plant Cannabis sativa L. and any part of such plant, whether growing or not, with a delta-nine tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis. Deems Cannabis sativa L. to meet that concentration limit if a person grows or processes it for purposes of making industrial hemp in accordance with state law.


Summary:
Methamphetamine Education, Treatment, and Hope Act of 2010 - Amends the Public Health Service Act to require the Director of the Center for Substance Abuse Treatment to collaborate with professionals in the addiction field and primary health care providers to raise awareness about how to: (1) recognize the signs of a substance abuse disorder; and (2) apply evidence-based practices for screening and treating individuals with, or at-risk for developing, an addiction.

Revises requirements governing a grant program for substance abuse residential treatment for pregnant and parenting women (currently, for postpartum women), to include treatment for addiction to methamphetamine, outpatient treatment services, and referrals for dental services.

Requires the Director to give grant priority to a program serving an area that: (1) is a rural area, an area with a shortage of mental health professionals, or an area with a shortage of family-based substance abuse treatment options; and (2) has high rates of addiction to methamphetamine or other drugs.

Revises requirements for biennial reports to Congress to require such reports to include: (1) data on the number of pregnant and parenting women in need of, but not receiving, treatment for substance abuse; and (2) data on recovery and relapse rates of women receiving treatment for substance abuse under the grant program.

Requires the Director to expand, intensify, and coordinate efforts to provide pregnant and parenting women treatment for addiction to methamphetamine or other drugs.

Requires the Director of the Office for Substance Abuse Prevention to: (1) maintain a clearinghouse that provides information and educational materials to employers and employees about comprehensive drug-free workplace programs and substance abuse prevention and treatment resources; and (2) support the involvement of youth in the development and implementation of prevention strategies focused on youth.

treatment hope act amends public_health_service_act require director center_for_substance_abuse_treatment collaborate professionals addiction field primary health care providers raise awareness recognize signs substance abuse disorder apply evidence based practices screening treating individuals risk developing addiction revises requirements governing grant program substance abuse residential treatment pregnant parenting women currently postpartum women include treatment addiction methamphetamine outpatient treatment services referrals dental services requires director grant priority program serving area rural area area shortage mental health professionals area shortage family based substance abuse treatment options high rates addiction methamphetamine drugs revises requirements biennial reports congress require reports include data number pregnant parenting women need receiving treatment substance abuse data recovery rates women receiving treatment substance abuse grant program requires director expand intensify coordinate efforts provide pregnant parenting women treatment addiction methamphetamine drugs requires director maintain clearinghouse provides information educational materials employers employees comprehensive drug free workplace programs substance abuse prevention treatment resources support involvement youth development implementation prevention strategies focused youth


Summary: States' Medical Marijuana Property Rights Protection Act - Exempts real property from civil forfeiture under the Controlled Substances Act due to medical marijuana-related conduct that is authorized by state law.

states medical marijuana property rights protection act exempts real property civil forfeiture controlled substances act medical marijuana related conduct authorized state law


Summary: Respect States' and Citizens' Rights Act of 2013 - Amends the Controlled Substances Act to provide that, in the case of any state law that pertains to marihuana, no provision of such Act shall be construed as indicating congressional intent to: (1) occupy the field in which that provision operates, including criminal penalties, to the exclusion of state law on the same subject matter; or (2) preempt any such state law.

amends controlled substances act provide case state law pertains marihuana provision act shall construed indicating congressional intent occupy field provision operates including criminal penalties exclusion state law subject matter preempt state law


Summary:
Amends the Controlled Substances Act to remove dihydrocodeinone (hydrocodone) from classification as a schedule III controlled substance.

Directs the Attorney General to immediately allow manufacturers and distributors to store hydrocodone compound products in accordance with the physical security requirements for schedule III, IV, and V controlled substances for three years beginning on the date enactment of this Act.

Requires the Comptroller General to submit a report on the reclassification of hydrocodone products under this Act, including: (1) an assessment of the degree to which the reclassification of such products under this Act impacts the ability of patients with legitimate medical needs, particularly those in rural areas and nursing home facilities, to access adequate pain management; and (2) recommendations necessary to address any issues relating to patient access to adequate pain management.

amends controlled substances act remove hydrocodone classification schedule iii controlled substance directs attorney general immediately allow manufacturers distributors store hydrocodone compound products accordance physical security requirements schedule iii controlled substances years beginning date enactment act requires comptroller general submit report reclassification hydrocodone products act including assessment degree reclassification products act impacts ability patients legitimate medical needs particularly rural areas nursing home facilities access adequate pain management recommendations necessary address issues relating patient access adequate pain management


Summary: Respect State Marijuana Laws Act of 2013 - Amends the Controlled Substances Act to provide that provisions of such Act related to marihuana shall not apply to any person acting in compliance with state laws relating to the production, possession, distribution, dispensation, administration, or delivery of marihuana.

respect state amends controlled substances act provide provisions act related marihuana shall apply person acting compliance state laws relating production possession distribution dispensation administration delivery marihuana


Summary:
Protect our Native Women Act of 2013 - Amends the Indian Law Enforcement Reform Act to require each Assistant U.S. Attorney serving as tribal liaison for a district to serve as a domestic violence tribal liaison.

Requires domestic violence tribal liaisons to:

 encourage and assist in arrests and federal prosecutions for domestic violence, dating violence, sexual assault, and stalking in Indian country; train law enforcement officers and others responsible for responding to crimes in Indian country; develop multidisciplinary teams to combat domestic and sexual violence against Indians; work with tribal justice officials and victims' advocates to address any backlog in the prosecution of domestic violence, dating violence, sexual assault, and stalking in Indian country; and develop working relationships and maintain communication with tribal leaders, tribal community and victims' advocates, and tribal justice officials to exchange information with tribal justice officials. Directs the Attorney General to appoint qualified tribal prosecutors and other qualified attorneys to assist in prosecuting federal offenses committed in the Indian country of at least ten federally recognized tribes. Gives a preference to those tribes that have the highest rates of domestic violence and sexual assault.

Directs the Comptroller General to report to Congress on: (1) the prevalence of domestic violence and sexual assault in Indian country, (2) the efforts of federal law enforcement agencies to investigate those crimes, and (3) federal initiatives to help address and prevent such violence.

protect native women act amends indian law enforcement reform act require assistant attorney serving tribal liaison district serve domestic violence tribal liaison requires domestic violence tribal liaisons encourage assist arrests federal prosecutions domestic violence dating violence sexual assault stalking indian country train law enforcement officers responsible responding crimes indian country develop multidisciplinary teams combat domestic sexual violence indians work tribal justice officials victims advocates address backlog prosecution domestic violence dating violence sexual assault stalking indian country develop working relationships maintain communication tribal leaders tribal community victims advocates tribal justice officials exchange information tribal justice officials directs attorney general appoint qualified tribal prosecutors qualified attorneys assist prosecuting federal offenses committed indian country federally recognized tribes gives preference tribes highest rates domestic violence sexual assault directs comptroller general report congress prevalence domestic violence sexual assault indian country efforts federal law enforcement agencies investigate crimes federal initiatives help address prevent violence


Summary:
Transnational Drug Trafficking Act of 2013 - Amends the Controlled Substances Import and Export Act to prohibit the manufacture or distribution of a controlled substance in schedule I or II, flunitrazepam, or a listed chemical by individuals having reasonable cause to believe that such substance or chemical will be unlawfully imported into the United States or into waters within 12 miles of the U.S. coast.

Prohibits the manufacture or distribution of a listed chemical: (1) intending or knowing that it will be used to manufacture a controlled substance; and (2) intending, knowing, or having reasonable cause to believe that the substance will be unlawfully imported into the United States.

Amends the federal criminal code to revise the prohibition against, and penalties for, intentionally trafficking in a counterfeit drug to apply to intentionally trafficking in a drug and knowingly using a counterfeit mark on or in connection with such drug.

amends controlled_substances_import_and_export_act prohibit manufacture distribution controlled substance schedule flunitrazepam listed chemical individuals having reasonable cause believe substance chemical unlawfully imported united_states waters miles coast prohibits manufacture distribution listed chemical intending knowing manufacture controlled substance intending knowing having reasonable cause believe substance unlawfully imported united_states amends federal criminal code revise prohibition penalties intentionally trafficking counterfeit drug apply intentionally trafficking drug knowingly counterfeit mark connection drug


Summary: Small Business Tax Equity Act of 2013 - Amends the Internal Revenue Code to exempt a trade or business that conducts marijuana sales in compliance with state law from the prohibition against allowing business-related tax credits or deductions for expenditures in connection with trafficking in controlled substances.

amends internal revenue code exempt trade business conducts marijuana sales compliance state law prohibition allowing business related tax credits deductions expenditures connection trafficking controlled substances


Summary:
Amends the Controlled Substances Act to: (1) impose an additional term of up to ten years' imprisonment for cultivating or manufacturing controlled substances on federal property; (2) prohibit a person, while cultivating or manufacturing a controlled substance on federal property, from clear cutting timber or diverting, obstructing, or draining an aquifer, spring, stream, river or body of water; and (3) apply the prohibition against assembling, maintaining, or placing a boobytrap on federal property where a controlled substance is being manufactured to federal property where a controlled substance is being cultivated.

Directs the U.S. Sentencing Commission to amend the Federal Sentencing Guidelines to provide an additional penalty increase of two offense levels if the offense of manufacturing, distributing, or dispensing, or possessing with intent to manufacture, distribute, or dispense a controlled substance or a counterfeit substance: (1) includes the use of a poison, chemical, or other hazardous substance to cultivate or manufacture controlled substances on federal property; (2) creates a hazard to humans, wildlife, or domestic animals; (3) degrades or harms the environment or natural resources; (4) pollutes an aquifer, spring, stream, river, or body of water; (5) involves the diversion, redirection, obstruction, or draining of an aquifer, spring, stream, river, or body of water or the clear cut of timber while cultivating or manufacturing a controlled substance on federal property; or (6) involves the possession of a firearm while cultivating or manufacturing controlled substances on federal lands.

amends controlled substances act impose additional term years imprisonment cultivating manufacturing controlled substances federal property prohibit person cultivating manufacturing controlled substance federal property clear cutting timber diverting obstructing draining aquifer spring stream river body water apply prohibition assembling maintaining placing federal property controlled substance manufactured federal property controlled substance cultivated directs amend federal sentencing guidelines provide additional penalty increase offense levels offense manufacturing distributing dispensing possessing intent manufacture distribute dispense controlled substance counterfeit substance includes use poison chemical hazardous substance manufacture controlled substances federal property creates hazard humans wildlife domestic animals harms environment natural resources aquifer spring stream river body water involves diversion obstruction draining aquifer spring stream river body water clear cut timber cultivating manufacturing controlled substance federal property involves possession firearm cultivating manufacturing controlled substances federal lands


Summary: Fairness in Cocaine Sentencing Act of 2013 - Amends the Controlled Substances Act and the Controlled Substances Import and Export Act to eliminate increased and mandatory minimum penalties for drug offenses involving mixtures or substances which contain cocaine base (i.e., crack cocaine).

fairness amends controlled substances act controlled_substances_import_and_export_act eliminate increased mandatory minimum penalties drug offenses involving mixtures substances contain cocaine base crack cocaine


Summary:
Major Drug Trafficking Prosecution Act of 2013 - Requires the Attorney General's prior written approval for a federal prosecution of an offense under the Controlled Substances Act (CSA) or the Controlled Substances Import and Export Act (CSIEA), or for any conspiracy to commit such an offense, where the offense involves the illegal distribution or possession of a controlled substance in an amount less than that specified as a minimum for an offense under CSA or, in the case of any substance containing cocaine or cocaine base, in an amount less than 500 grams.

Modifies CSA and CSIEA to delete specified mandatory minimum terms of imprisonment.

requires attorney general prior written approval federal prosecution offense controlled substances act csa controlled_substances_import_and_export_act csiea conspiracy commit offense offense involves illegal distribution possession controlled substance specified minimum offense csa case substance containing cocaine cocaine base grams modifies csa csiea delete specified mandatory minimum terms imprisonment


Summary:
Smarter Sentencing Act of 2013 - Amends the federal criminal code to direct the court to impose a sentence for specified controlled substance offenses without regard to any statutory minimum sentence if the court finds that the criminal history category for the defendant is not higher than category two. (Currently, the court may disregard the statutory minimum if the defendant does not have more than one criminal history point.)

Authorizes a court that imposed a sentence for a crack cocaine possession or trafficking offense committed before August 3, 2010, on motion of the defendant, the Director of the Bureau of Prisons, the attorney for the government, or the court, to impose a reduced sentence as if provisions of the Fair Sentencing Act of 2010 were in effect at the time such offense was committed.

Amends the Controlled Substances Act (CSA) and the Controlled Substances Import and Export Act (CSIEA) to reduce mandatory minimum sentences for manufacturing, distributing, dispensing, possessing, importing, or exporting specified controlled substances.

Directs the Commission to review and amend its guidelines and policy statements applicable to persons convicted of such an offense under the CSA and CSIEA to ensure consistency with this Act and to consider specified factors, including: (1) its mandate to formulate guidelines to minimize the likelihood that the federal prison population will exceed federal prison capacity, (2) fiscal implications of changes, (3) relevant public safety concerns, (4) the intent of Congress that penalties for violent and serious drug traffickers who present public safety risks remain appropriately severe, and (5) the need to reduce and prevent racial disparities in sentencing.

Requires the Attorney General to report on how the reduced expenditures on federal corrections and cost savings resulting from this Act will be used to help reduce overcrowding, increase investment in law enforcement and crime prevention, and reduce recidivism.

amends federal criminal code direct court impose sentence specified controlled substance offenses regard statutory minimum sentence court finds criminal history category defendant higher category currently court disregard statutory minimum defendant criminal history point authorizes court imposed sentence crack cocaine possession trafficking offense committed august motion defendant director bureau_of_prisons attorney government court impose reduced sentence provisions fair sentencing act effect time offense committed amends controlled substances act csa controlled_substances_import_and_export_act csiea reduce mandatory minimum sentences manufacturing distributing dispensing possessing importing exporting specified controlled substances directs commission review amend guidelines policy statements applicable persons convicted offense csa csiea ensure consistency act consider specified factors including mandate formulate guidelines minimize likelihood federal prison population exceed federal prison capacity fiscal implications changes relevant public safety concerns intent congress penalties violent drug traffickers present public safety risks remain appropriately severe need reduce prevent racial disparities sentencing requires attorney general report reduced expenditures federal corrections cost savings resulting act help reduce increase investment law enforcement crime prevention reduce recidivism


Summary: Unmuzzle the Drug Czar Act of 2014 - Amends the Office of National Drug Control Policy Reauthorization Act of 1998 to repeal a provision requiring the Director of National Drug Control Policy to: (1) ensure that no federal funds appropriated to the Office of National Drug Control Policy are expended for any study or contract relating to the legalization (for a medical or any other use) of a substance listed in schedule I of the Controlled Substances Act (which includes marijuana), and (2) oppose any attempt to legalize the use of any such substance that the Food and Drug Administration (FDA) has not approved for use for medical purposes.

drug act amends office_of_national_drug_control_policy_reauthorization_act repeal provision requiring director national_drug_control_policy ensure federal funds appropriated office_of_national_drug_control_policy expended study contract relating legalization medical use substance listed schedule controlled substances act includes marijuana oppose attempt use substance food_and_drug_administration fda approved use medical purposes


Summary:
Ensuring Patient Access and Effective Drug Enforcement Act of 2013 - Amends the Controlled Substances Act to require registrants to manufacture, distribute, or dispense controlled substances to obtain a criminal background check on, and perform drug testing on, each employee with access to facility areas where controlled substances are stored. Requires such background checks to be obtained when such an employee is hired and periodically thereafter, but not more frequently than every two years. Authorizes registration suspension or revocation and a $10,000 penalty for failing to comply with such requirements.

Requires the Attorney General, before revoking or suspending a registration under such Act, to: (1) provide the registrant notice of the grounds for doing so, and where such grounds consist of a legal violation, a specific citation to such law; (2) give the registrant an opportunity to submit a corrective action plan within a reasonable time period; and (3) determine whether, in light of the plan, revocation or suspension proceedings should be discontinued or deferred or additional changes need to be made in such plan.

Establishes the Combating Prescription Drug Abuse Working Group to: (1) report on federal initiatives to reduce prescription drug diversion and abuse, (2) identify gaps and opportunities to ensure the safe use of prescription drugs with the potential for diversion and abuse, (3) examine recommendations to transfer one or more controlled substances from schedule III to schedule II to evaluate the effectiveness of such a transfer in reducing diversion and abuse and any effect of such a transfer on access to prescription drugs for legitimate medical purposes, (4) make recommendations on specific ways to reduce the diversion and abuse of prescription drugs, and (5) report on its efforts to prevent or reduce prescription drug diversion and abuse to ensure that patients continue to have access to medications.

ensuring patient access effective drug enforcement act amends controlled substances act require registrants manufacture distribute dispense controlled substances obtain criminal background check perform drug testing employee access facility areas controlled substances stored requires background checks obtained employee hired periodically frequently years authorizes registration suspension revocation penalty failing comply requirements requires attorney general revoking suspending registration act provide registrant notice grounds grounds consist legal violation specific citation law registrant opportunity submit corrective action plan reasonable time period determine light plan revocation suspension proceedings discontinued deferred additional changes need plan report federal initiatives reduce prescription drug diversion abuse identify gaps opportunities ensure safe use prescription drugs potential diversion abuse examine recommendations transfer controlled substances schedule iii schedule evaluate effectiveness transfer reducing diversion abuse effect transfer access prescription drugs legitimate medical purposes recommendations specific ways reduce diversion abuse prescription drugs report efforts prevent reduce prescription drug diversion abuse ensure patients continue access medications


Summary:
Ready to Work Act - Directs the Secretary of Labor, not later than one year after enactment of this Act, to issue a final rule pursuant to the Social Security Act that allows a state to enact legislation to test an applicant for unemployment compensation for use of controlled substances as a condition for receiving such compensation, if that applicant is an individual for whom suitable work is only available in an occupation that regularly conducts drug testing.

Prescribes a special rule providing that, if the Secretary has not issued an interim final rule within 180 days after enactment of this Act, the final rule shall require the state unemployment compensation agency to determine whether an occupation regularly conducts drug testing.

ready work act directs secretary labor later year enactment act issue final rule pursuant social_security_act allows state enact legislation test applicant unemployment compensation use controlled substances condition receiving compensation applicant individual suitable work available occupation regularly conducts drug testing prescribes special rule providing secretary issued interim final rule days enactment act final rule shall require state unemployment compensation agency determine occupation regularly conducts drug testing


Summary:
Legitimate Use of Medical Marijuana Act or the LUMMA - Transfers marijuana from schedule I to schedule II of the Controlled Substances Act (CSA).

Provides that in a state in which marijuana may be prescribed for medical use under state law, no provision of the CSA or of the Federal Food, Drug, and Cosmetic Act shall prohibit or otherwise restrict: (1) the prescription of marijuana for medical use; (2) an authorized patient from obtaining, possessing, transporting, or using marijuana for that individual's medical use; (3) an individual from obtaining, possessing, transporting, or manufacturing marijuana pursuant to an authorization under state law; (4) a pharmacy or other entity authorized under state law to distribute medical marijuana to an authorized patient for medical use from obtaining, possessing, or distributing marijuana for that purpose; or (5) an entity authorized by such state from producing, processing, or distributing marijuana for  prescribed medical use.

legitimate use medical transfers marijuana schedule schedule controlled substances act csa provides state marijuana prescribed medical use state law provision csa cosmetic act shall prohibit restrict prescription marijuana medical use authorized patient obtaining possessing transporting marijuana individual medical use individual obtaining possessing transporting manufacturing marijuana pursuant authorization state law pharmacy entity authorized state law distribute medical marijuana authorized patient medical use obtaining possessing distributing marijuana purpose entity authorized state producing processing distributing marijuana prescribed medical use


Summary: Stop Meth Labs and Enhance Patient Access Act of 2014 - Amends the Controlled Substances Act to authorize the Attorney General to exempt a scheduled listed chemical product from specified requirements regarding sales quantity, nonliquid forms, and retail transactions upon determining that it is not practical by processes known to be employed by clandestine laboratory operators to use the product in the illicit manufacture of methamphetamine (currently, upon determining that the product cannot be used in the illicit manufacture of methamphetamine).

stop labs enhance patient access act amends controlled substances act authorize attorney general exempt scheduled listed chemical product specified requirements sales quantity forms retail transactions determining practical processes known employed clandestine laboratory operators use product illicit manufacture methamphetamine currently determining product illicit manufacture methamphetamine


Summary:
Western Hemisphere Drug Policy Commission Act of 2014 - Establishes the Western Hemisphere Drug Policy Commission, which shall: (1) conduct a comprehensive review of U.S. foreign policy in the Western Hemisphere to reduce the illicit drug supply and drug abuse and reduce the damage associated with illicit drug markets and trafficking, and (2) identify policy and program options to improve existing international and domestic counternarcotics policy.

Terminates the Commission 60 days after submission of its report.

act establishes shall conduct comprehensive review foreign policy western_hemisphere reduce illicit drug supply drug abuse reduce damage associated illicit drug markets trafficking identify policy program options improve existing international domestic counternarcotics policy terminates commission days submission report


Summary:
Ensuring Patient Access and Effective Drug Enforcement Act of 2014 - Amends the Controlled Substances Act to define: (1) "factors as may be relevant to and consistent with the public health and safety," for purposes of the Attorney General's determination of whether registering an applicant to manufacture or distribute a controlled substance in schedule I or II is in the public interest, as factors that are relevant to and consistent with the findings of such Act; and (2) "imminent danger to the public health or safety," for purposes of the suspension of such a registration, to mean that in the absence of an immediate suspension order, controlled substances will continue to be intentionally diverted outside of legitimate distribution channels or distributed or dispensed outside the usual course of professional practices or in a manner that poses a present or foreseeable risk of serious adverse health consequences or death.

Requires an order to show cause as to why such a registration should not be denied, revoked, or suspended to: (1) contain a statement of the basis for the denial, revocation, or suspension, including specific citations to any laws or regulations alleged to be violated; (2) direct the applicant or registrant to appear before the Attorney General at a specific place and time within 30 days after receipt of the order; and (3) notify the applicant or registrant of the opportunity to submit a corrective action plan on or before such appearance. Requires the Attorney General, upon review of any such plan, to determine whether denial, revocation, or suspension proceedings should be discontinued or deferred for purposes of modifications to such plan. Makes such requirements inapplicable to the issuance of an immediate suspension order.

Directs the Secretary of Health and Human Services (HHS), acting through the Commissioner of Food and Drugs (FDA) and the Director of the Centers for Disease Control and Prevention (CDC), to submit a report identifying: (1) obstacles to legitimate patient access to controlled substances; (2) issues with diversion of controlled substances; and (3) how collaboration between federal, state, local, and tribal law enforcement agencies and the pharmaceutical industry can benefit patients and prevent diversion and abuse of controlled substances.

ensuring patient access effective drug enforcement act amends controlled substances act define factors relevant consistent public health safety purposes attorney general determination registering applicant manufacture distribute controlled substance schedule public interest factors relevant consistent findings act imminent danger public health safety purposes suspension registration mean absence immediate suspension order controlled substances continue intentionally diverted outside legitimate distribution channels distributed dispensed outside usual course professional practices manner poses present foreseeable risk adverse health consequences death requires order cause registration denied revoked suspended contain statement basis denial revocation suspension including specific citations laws regulations alleged violated direct applicant registrant appear attorney general specific place time days receipt order notify applicant registrant opportunity submit corrective action plan appearance requires attorney general review plan determine denial revocation suspension proceedings discontinued deferred purposes modifications plan makes requirements inapplicable issuance immediate suspension order directs secretary health_and_human_services hhs acting commissioner food drugs fda director centers_for_disease_control_and_prevention cdc submit report identifying obstacles legitimate patient access controlled substances issues diversion controlled substances collaboration federal state local tribal law enforcement agencies pharmaceutical industry benefit patients prevent diversion abuse controlled substances


Summary:
(This measure has not been amended since it was passed by the House on September 15, 2014. The summary of that version is repeated here.)

Designer Anabolic Steroid Control Act of 2014 - Amends the Controlled Substances Act to add specified substances to the list of those included within the definition of "anabolic steroid." Provides that a drug or hormonal substance (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone) that is not listed and that is derived from, or has a chemical structure substantially similar to, an anabolic steroid that is listed, shall be considered to be an anabolic steroid for purposes of such Act if it: (1) has been created or manufactured with the intent of producing a substance that either promotes muscle growth or otherwise causes a pharmacological effect similar to that of testosterone; or (2) has been, or is intended to be, promoted in any manner suggesting that consuming it will promote any pharmacological effect similar to that of testosterone.

Prohibits a substance from being considered to be a drug or hormonal substance for purposes of such Act if it is: (1) an herb or other botanical, a concentrate, metabolite, or extract of, or a constituent isolated directly from, an herb or other botanical, or a combination of two or more such substances; or (2) a dietary ingredient for purposes of the Federal Food, Drug, and Cosmetic Act and is not anabolic or androgenic. Requires any person claiming the benefit of such an exception to bear the burden of providing the appropriate evidence.

 Authorizes the Attorney General to issue an order adding a drug or other substance to the definition of "anabolic steroid" upon finding that: (1) the substance satisfies the criteria for being considered an anabolic steroid, and (2) such addition will assist in preventing abuse or misuse of the substance.

 Prohibits importing, exporting, manufacturing, distributing, dispensing, or possessing with intent to manufacture, distribute, or dispense any anabolic steroid, or any product containing an anabolic steroid, unless it bears a label clearly identifying the anabolic steroid by the nomenclature used by the International Union of Pure and Applied Chemistry (IUPAC). Prescribes penalties. Sets forth an exemption from such IUPAC nomenclature requirement if such product is labeled in the manner required under the Federal Food, Drug, and Cosmetic Act, as described in this Act.

Authorizes the Attorney General to: (1) collect data and analyze products to determine whether they contain anabolic steroids and are properly labeled, and (2) publish a list of products containing an anabolic steroid that are not properly labeled.

measure amended passed house september summary version repeated designer anabolic steroid control act amends controlled substances act add specified substances list included definition anabolic steroid provides drug substance listed derived chemical structure substantially similar anabolic steroid listed shall considered anabolic steroid purposes act created manufactured intent producing substance promotes growth causes pharmacological effect similar intended promoted manner consuming promote pharmacological effect similar prohibits substance considered drug substance purposes act botanical concentrate extract constituent isolated directly botanical combination substances dietary ingredient purposes cosmetic act anabolic requires person claiming benefit exception bear burden providing appropriate evidence authorizes attorney general issue order adding drug substance definition anabolic steroid finding substance satisfies criteria considered anabolic steroid addition assist preventing abuse misuse substance prohibits importing exporting manufacturing distributing dispensing possessing intent manufacture distribute dispense anabolic steroid product containing anabolic steroid bears label clearly identifying anabolic steroid international_union_of_pure_and_applied_chemistry prescribes penalties sets forth exemption requirement product labeled manner required cosmetic act described act authorizes attorney general collect data analyze products determine contain anabolic steroids properly labeled publish list products containing anabolic steroid properly labeled


Summary:
Synthetic Abuse and Labeling of Toxic Substances Act of 2014 or the SALTS Act - Amends the Controlled Substances Act to provide that, in determining whether a controlled substance analogue was intended for human consumption, the following factors may be considered: (1) the marketing, advertising, and labeling of the substance; (2) the known efficacy or usefulness of the substance for the marketed, advertised, or labeled purpose; (3) the difference between the price at which the substance is sold and the price at which the substance it is purported to be or advertised as is normally sold; (4) the diversion of the substance from legitimate channels and the clandestine importation, manufacture, or distribution of the substance; and (5) whether the defendant knew or should have known that the substance was intended to be consumed by injection, inhalation, ingestion, or any other immediate means.

Declares that evidence that a substance was not marketed, advertised, or labeled for human consumption shall not by itself be sufficient to establish that the substance was not intended for human consumption.

labeling toxic substances act salts act amends controlled substances act provide determining controlled substance analogue intended human consumption following factors considered marketing advertising labeling substance known efficacy usefulness substance marketed advertised labeled purpose difference price substance sold price substance purported advertised normally sold diversion substance legitimate channels clandestine importation manufacture distribution substance defendant knew known substance intended consumed injection inhalation ingestion immediate means declares evidence substance marketed advertised labeled human consumption shall sufficient establish substance intended human consumption


Summary:
Charlotte's Web Medical Hemp Act of 2014 - Amends the Controlled Substances Act to exclude therapeutic hemp and cannabidiol: (1) from the definition of "marihuana," and (2) from treatment as a controlled substance under such Act. Defines: (1) "therapeutic hemp" to mean the plant Cannabis sativa L. and any part of such plant with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis; and (2) "cannabidiol" to mean the substance cannabidiol, as derived from therapeutic hemp.

Exempts therapeutic hemp or cannabidiol from the Federal Food, Drug, and Cosmetic Act.

Declares that nothing in this Act shall restrict any activities related to the use, production, or distribution of marihuana in a state in which such activities are legal under state law.

web medical hemp act amends controlled substances act exclude therapeutic hemp cannabidiol definition marihuana treatment controlled substance act defines therapeutic hemp mean plant cannabis sativa plant delta-9 tetrahydrocannabinol concentration percent dry weight basis cannabidiol mean substance cannabidiol derived therapeutic hemp exempts therapeutic hemp cannabidiol cosmetic act declares act shall restrict activities related use production distribution marihuana state activities legal state law


Summary:
Fifth Amendment Integrity Restoration Act of 2014 or the FAIR Act - Amends the federal criminal code to increase the federal government's burden of proof in civil forfeiture proceedings to clear and convincing evidence. Requires the government, in addition to showing a substantial connection between the seized property and the offense in a forfeiture proceeding, to establish by clear and convincing evidence that the owner of any interest in the seized property intentionally used the property in connection with the offense or knowingly consented or was willfully blind to the use of the property by another in connection with the offense.

Requires proceeds from the disposition of forfeited property to be deposited into the General Fund of the Treasury, rather than to Department of Justice (DOJ) accounts for law enforcement activities.

fair act amends federal criminal code increase federal government burden proof civil forfeiture proceedings clear convincing evidence requires government addition showing substantial connection seized property offense forfeiture proceeding establish clear convincing evidence owner interest seized property intentionally property connection offense knowingly consented willfully blind use property connection offense requires proceeds disposition forfeited property deposited general_fund treasury department_of_justice doj accounts law enforcement activities


Summary: Protecting Public Safety and Federal Resources Act - Disapproves amendment number 3 of the Amendments to the Sentencing Guidelines submitted by the U.S. Sentencing Commission to Congress on April 30, 2014, relating to statutory mandatory minimum penalties for drug trafficking offenses.

act disapproves amendment number amendments sentencing guidelines submitted congress april relating statutory mandatory minimum penalties drug trafficking offenses


Summary:
Comprehensive Addiction and Recovery Act of 2014 - Directs the Department of Health and Human Services (HHS) to convene a Pain Management Best Practices Interagency Task Force.

Authorizes the Attorney General to make grants to address drug abuse, including for educational efforts, communitywide strategies that address local drug crises, alternative to incarceration programs, disposal sites for unwanted prescription medications, educational programs for offenders, programs to address the use of opioids among pregnant and parenting female offenders, and veterans treatment court programs.

Amends the Public Health Service Act to authorize the Center for Substance Abuse Treatment to award grants to state substance abuse agencies, units of local government, nonprofit organizations, and Indian tribes or tribal organizations that have a high rate, or have had a rapid increase, in the use of opioids.

Directs the Attorney General to make grants for medication assisted treatment programs through criminal justice agencies, initiatives involving young people, and recovery services.

 Amends the Higher Education Act of 1965 to prohibit the Department of Education (ED) from including any question about the conviction of an applicant for the possession or sale of illegal drugs on the Free Application for Federal Student Aid (FAFSA) form.

Directs HHS to establish a bipartisan Task Force on Recovery and Collateral Consequences (collateral consequences are penalties imposed on an individual as a result of a criminal conviction but not as part of the court judgment, or optionally imposed by an administrative agency, official, or civil court).

 Requires grants under this Act to give priority to states that provide civil liability protection for individuals administering naloxone (a prescription drug used to rapidly reverse an opioid overdose) to counteract opioid overdoses.

comprehensive addiction recovery act directs department_of_health_and_human_services hhs convene pain management best practices interagency task force authorizes attorney general grants address drug abuse including educational efforts communitywide strategies address local drug crises alternative incarceration programs disposal sites unwanted prescription medications educational programs offenders programs address use opioids pregnant parenting female offenders veterans treatment court programs amends public_health_service_act authorize center_for_substance_abuse_treatment award grants state substance abuse agencies units local government nonprofit organizations indian tribes tribal organizations high rate rapid increase use opioids directs attorney general grants medication assisted treatment programs criminal justice agencies initiatives involving young people recovery services amends higher education act prohibit including question conviction applicant possession sale illegal drugs form directs hhs establish bipartisan task force recovery collateral consequences collateral consequences penalties imposed individual result criminal conviction court judgment imposed administrative agency official civil court requires grants act priority states provide civil liability protection individuals administering naloxone prescription drug rapidly reverse opioid overdose opioid


Summary:
Fifth Amendment Restoration Act of 2014 - Prohibits government seizures of private property under any federal law providing for civil asset forfeiture.

Defines "property" to include real property, financial assets, and commonly held property owned by more than one person.

Bars federal agencies from: (1) participating in or benefiting from any multiple-jurisdiction, equitable sharing, or shared civil asset forfeiture program with any state or local government; or (2) accepting or adopting property seized by a state or local government.

Excludes from such prohibitions: (1) contraband, including illegal imports or exports, and anything the possession of which is a crime; or (2) property subject to forfeiture or seizure because the owner has first been convicted of a criminal offense.

fifth amendment restoration act prohibits government seizures private property federal law providing civil asset forfeiture defines property include real property financial assets commonly held property owned person bars federal agencies participating benefiting multiple jurisdiction equitable sharing shared civil asset forfeiture program state local government accepting adopting property seized state local government excludes prohibitions contraband including illegal imports exports possession crime property subject forfeiture seizure owner convicted criminal offense


Summary: Industrial Hemp Farming Act of 2013 - Amends the Controlled Substances Act to exclude industrial hemp from the definition of "marihuana." Defines "industrial hemp" to mean the plant Cannabis sativa L. and any part of such plant, whether growing or not, with a delta-nine tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis. Deems Cannabis sativa L. to meet that concentration limit if a person grows or processes it for purposes of making industrial hemp in accordance with state law, unless the Attorney General determines that the state law is not reasonably calculated to comply with such definition.

industrial hemp farming act amends controlled substances act exclude industrial hemp definition marihuana defines industrial hemp mean plant cannabis sativa plant growing delta tetrahydrocannabinol concentration percent dry weight basis sativa meet concentration limit person grows processes purposes making industrial hemp accordance state law attorney general determines state law reasonably calculated comply definition


Summary:
Safe Prescribing Act of 2013 - Amends the Controlled Substances Act to remove dihydrocodeinone (hydrocodone) from classification as a schedule III controlled substance.

Directs the Attorney General to immediately allow manufacturers and distributors to store hydrocodone combination products in accordance with the physical security requirements for schedule III, IV, and V controlled substances for three years beginning on the date of enactment of this Act.

Requires the Comptroller General to submit a report on the reclassification of hydrocodone products under this Act, including: (1) an assessment of the degree to which the reclassification of such products under this Act impacts the ability of patients with legitimate medical needs, particularly those in rural areas and nursing home facilities, to access adequate pain management; and (2) recommendations necessary to address any issues relating to patient access to adequate pain management.

safe prescribing act amends controlled substances act remove hydrocodone classification schedule iii controlled substance directs attorney general immediately allow manufacturers distributors store hydrocodone combination products accordance physical security requirements schedule iii controlled substances years beginning date enactment act requires comptroller general submit report reclassification hydrocodone products act including assessment degree reclassification products act impacts ability patients legitimate medical needs particularly rural areas nursing home facilities access adequate pain management recommendations necessary address issues relating patient access adequate pain management